Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
D000222:Adaptation, Physiological; D000818:Animals; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D004789:Enzyme Activation; D053767:Glucagon-Like Peptide 2; D004763:Glucagon-Like Peptides; D006801:Humans; D007082:Ileum / Q000473:pathology; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000473:pathology; D007422:Intestines / Q000187:drug effects* / Q000503:physiopathology*; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D009004:Monosaccharide Transport Proteins / Q000378:metabolism; D010289:Parenteral Nutrition, Total; D010455:Peptides / Q000494:pharmacology*; D010539:Permeability; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D012778:Short Bowel Syndrome / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D051269:Sodium-Glucose Transporter 1
D053767:Glucagon-Like Peptide 2; D008562:Membrane Glycoproteins; D009004:Monosaccharide Transport Proteins; D010455:Peptides; D011994:Recombinant Proteins; C495674:SLC5A1 protein, human; C495676:Slc5a1 protein, rat; D051269:Sodium-Glucose Transporter 1; D004763:Glucagon-Like Peptides; C505407:CASP3 protein, human; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases